PILA regulatory approval and improved solvency cited in half-year results
TradingView News reports PILA regulatory approval for a key obesity trial and improved solvency highlighted in its half-year results.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.